FDA Clearance Tracker · K070648
THE INHIBITOR, MODEL 001
Last checked: Nov 19, 2026Latest source record: Jun 29, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Jun 29, 2007
Substantially Equivalent
Time to decision
113 days
Received Mar 8, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K070648
- Device name
- THE INHIBITOR, MODEL 001
- Applicant
- Melmedtronics, Inc.
- Applicant location
- Hurst, TX
- Received
- Mar 8, 2007
- Decided
- Jun 29, 2007
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Masker, Tinnitus (KLW)
- Device class
- Class II
- Regulation
- 21 CFR 874.3400
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KLW. The earliest in FDA's data is K770938, decided Jun 28, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K070648
- The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Melmedtronics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.